Leuprorelin Acetate 3.75mg Injection: Clinical Trials

2 trials of Leuprorelin Acetate 3.75mg Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 41Completed 1

Follow this drug Literature Review of Leuprorelin Acetate 3.75mg Injection trials Research Report on Leuprorelin Acetate 3.75mg Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
Leuprorelin Acetate, Leuprorelin Acetate 3.75mg Injection - Endometriosis
Phase 1RecruitingZhuhai Huahaikang Pharmaceutical Technology Co., Ltd.302026-08-312026-09-02
Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine
Ziyinxiehuo Granules Herbs, Megestrol Acetate Tablet, Leuprorelin Acetate 3.75mg Injection - Idiopathic Precocious Puberty
Phase 4CompletedChildren's Hospital of Fudan University1262019-08-152024-02-07

Conditions studied

Endometriosis (1)

Sponsors

Children's Hospital of Fudan University (1)  ·  Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. (1)

Countries

China (2)

Top investigators

Jian Yu, professor (1)